Funder: Breakthrough T1D

Due Dates: Rolling (LOI submission) | Deadlines may be set by specific RFAs; see program page

Funding Amounts: Typically up to $3,000,000 total over 3 years; company matching funds required; no indirect costs allowed.

Summary: Supports for-profit organizations to advance research, development, and commercialization of therapies or devices for type 1 diabetes in alignment with Breakthrough T1D’s priorities.

Key Information: LOI required; company must provide matching funds; contact Breakthrough T1D before applying.